Clinic business

nference Launches AI-Driven Platform and Expands Partnership with Mayo Clinic, Providing Access to One of Industry’s Deepest Real-World Datasets | Company

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sept. 21, 2022–

nference, a leading science-based software company transforming healthcare by making biomedical data calculable, today announced the launch of its AI-powered nSights platform, which will enable biopharmaceutical, medical device and diagnostics companies to directly access and engage with identified health data to advance research and discovery.

The company also expanded its exclusive 12-year strategic relationship with Mayo Clinic, providing partners and referral customers access to the Mayo Clinic platform’s extensive anonymized electronic health data across a range of diseases and therapeutic areas. . This expanded collaboration will increase access to data-derived insights and insights by establishing a Mayo Clinic-branded version of nSights, called Mayo Clinic Platform_Discover, built and supported by nference to help its partners solve some of the most complex.

nSights is a software platform that makes real-world data available across multiple data modalities (clinical, molecular, and imaging). The platform enables data mining, hypothesis generation, analysis, and data science capabilities, including algorithm development, for users from all walks of life. nSights provides a 360-degree longitudinal view of each patient by leveraging an array of biomedical information, such as electronic health records, electrocardiograms, X-ray images, and more. Future iterations will also include digital pathology and genomics. The platform is supported by a flexible data dictionary, enabling the generation of new patient-level analysis capabilities.

“The potential of electronic health data remains locked in medical centers and is often underutilized due to data complexity, privacy and security concerns,” said Mike Koenig, chief commercial officer at nference. “Our expanded collaboration with the Mayo Clinic Platform provides the framework for the deployment of nSights by nference and enables our customers to access anonymized ‘patient-level’ data to drive research and development of new therapies.” I look forward to continuing to build and strengthen our partnership with the Mayo Clinic team as we work together to improve healthcare through data-driven insights and insights.

Through the company’s partnerships with leading academic medical centers such as the Mayo Clinic, nSights provides access to the most comprehensive and comprehensive patient-level dataset available across all therapeutic areas, including cardiology, oncology, metabolic diseases, immunology and infectious diseases. The platform offers insights from structured and unstructured records, representing over 20 years of longitudinality, including data from over 520 million clinical notes, 1.3 billion lab test results, 10.2 billion treatment regimens, etc.

“Over the past year, our collaboration with nference, leveraging nSights, has accelerated clinical decision support and care significantly,” said Maneesh Goyal, COO, Mayo Clinic. Platform. “The insights and insights derived from data help us accelerate and improve innovation and address unmet patient needs everywhere.

About Interference

Through its powerful technology platform and software, nference is transforming healthcare by making biomedical knowledge calculable. Its partnership with the Mayo Clinic has given nference the opportunity to synthesize decades of institutional knowledge, producing real-world evidence in real time by converting large amounts of anonymized data into deep insights to advance the discovery and development of diagnostics and therapies. Its proprietary AI-enabled software platform, nSights, has been used to significantly accelerate life science research, development and clinical care, including biomarker discovery and validation, generation of real-world evidence leveraging real-world data, early disease detection, public health policy generation and validation, and more. nference is headquartered in Cambridge, Mass. Follow nference on LinkedIn and Twitter. Visit us at www.nference.com.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220921005189/en/

CONTACT: Andrea Sampson, Sampson Public Relations Group

asampson@sampsonprgroup.com

562.304.0301

KEYWORD: MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: OTHER HEALTH OTHER SCIENCES PHARMACEUTICAL RESEARCH SOFTWARE ARTIFICIAL INTELLIGENCE MEDICAL DEVICES INFECTIOUS DISEASES HOSPITALS GENETICS DATA MANAGEMENT SCIENCE TECHNOLOGY PRACTICE MANAGEMENT MANAGED CARE BIOTECHNOLOGY HEALTH HEALTH TECHNOLOGY

SOURCE: reference

Copyright BusinessWire 2022.

PUBLISHED: 09/21/2022 08:45 / DISK: 09/21/2022 08:47

http://www.businesswire.com/news/home/20220921005189/en

Copyright BusinessWire 2022.